Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models (vol 132, pg 1, 2022)

被引：1
|
作者：
Qi, Ming
Fan, Shuran
Huang, Maohua
Pan, Jinghua
Li, Yong
Miao, Qun
Lyu, Wenyu
Li, Xiaobo
Deng, Lijuan
Qiu, Shenghui
Liu, Tongzheng
Deng, Weiqing
Chu, Xiaodong
Jiang, Chang
He, Wenzhuo
Xia, Liangping
Yang, Yunlong
Hong, Jian
Qi, Qi
Yin, Wenqian
Liu, Xiangning
Shi, Changzheng
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei
机构：
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2023年 / 133卷 / 03期
关键词：
D O I：
10.1172/JCI168771
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] RETRACTION: ZFAS1 Promotes Colorectal Cancer Metastasis Through Modulating miR-34b/SOX4 Targeting (Retraction of Vol 79, Pg 387, 2021)
    Deng, Hong
    Wang, Mingming
    Xu, Qin
    Yao, Hui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (02) : 1581 - 1581
  • [42] The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (vol 24, pg 546, 2017)
    Kataoka, Masato
    Kanda, Mitsuro
    Ishigure, Kiyoshi
    Matsuoka, Hiroshi
    Sato, Yusuke
    Takahashi, Takao
    Tanaka, Chihiro
    Deguchi, Tomohiro
    Shibata, Yoshihisa
    Sato, Mikinori
    Inagaki, Hitoshi
    Matsui, Takanori
    Kondo, Akinobu
    Takano, Nao
    Tanaka, Haruyoshi
    Sakamoto, Junichi
    Oba, Koji
    Kondo, Ken
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S1064 - S1064
  • [43] Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis (vol 35, pg 651, 2016)
    Wang, G.
    Fu, Y.
    Yang, X.
    Luo, X.
    Wang, J.
    Gong, J.
    Hu, J.
    ONCOGENE, 2017, 36 (42) : 5915 - 5915
  • [44] Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer (vol 65, pg 14553, 2022)
    Luo, Dongdong
    Liu, Xiaochun
    Jiang, Leilei
    Guo, Zhikun
    Lv, Yan
    Tian, Xiaochen
    Wang, Xiaoyan
    Cui, Shuxiang
    Wan, Shengbiao
    Xu, Ximing
    Li, Xiaoyang
    Qu, Xianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (23) : 15991 - 15991
  • [45] RETRACTED: MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 (Retracted article. See vol. 15, pg. 469, 2022)
    Xia, Wenfei
    Liu, Yun
    Du, Yaying
    Cheng, Teng
    Hu, Xiaopeng
    Li, Xingrui
    ONCOTARGETS AND THERAPY, 2020, 13 : 769 - 782
  • [46] RETRACTION: Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR-signaling-dependent MMP7 modulation (Retraction of Vol 36, Pg 1129, 2015)
    Stigbrand, Torgny
    TUMOR BIOLOGY, 2017,
  • [47] RETRACTED: miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells (Retracted article. See vol. 14, pg. 674, 2022)
    Tian, Hang
    Hou, Lei
    Xiong, Yu-Mei
    Huang, Jun-Xiang
    Zhang, Wen-Hua
    Pan, Yong-Ying
    Song, Xing-Rong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (03): : 1492 - 1501
  • [48] RETRACTION: Chronic oxymatrine treatment induces resistance and epithelial-mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells (Retraction of Vol 39, Pg 967, 2018)
    Xiong, Yibai
    Wang, Jun
    Zhu, Huirong
    Liu, Lingshuang
    Jiang, Yi
    ONCOLOGY REPORTS, 2024, 51 (06)
  • [49] RETRACTION: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2 (Retraction of Vol 24, Pg 1012, 2021)
    Hong, Sen
    Li, Shiquan
    Bi, Miaomiao
    Yu, Haiyao
    Yan, Zhenkun
    Liu, Tao
    Wang, Helei
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 33 : 208 - 208
  • [50] RETRACTED: MicroRNA-1297 inhibits metastasis and epithelial-mesenchymal transition by targeting AEG-1 in cervical cancer (Retracted article. See vol. 48, pg. 157, 2022)
    Wang, Zengyan
    He, Shanyang
    Guo, Peng
    Guo, Xu
    Zheng, Jingxuan
    ONCOLOGY REPORTS, 2017, 38 (05) : 3121 - 3129
12345